Ambea ABCHIX:AMBEAS 83 Receivables Turnover is 2.81 as of Mar. 2026. GuruFocus rates CHIX:AMBEAS with a GF Score™ of 83/100 and a GF Value™ of kr110.46 (Significantly Overvalued). The stock has 8 warning signs investors should review. Among 656 Healthcare Providers & Services companies, Ambea AB ranks better than 67.38% on this metric.
The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Ambea AB's Revenue for the
three
months ended in Mar. 2026 was kr4,220 Mil. Ambea AB's average Accounts Receivable for the
three
months ended in Mar. 2026 was kr1,501 Mil.
Hence, Ambea AB's Receivables Turnover for the
three
months ended in Mar. 2026 was 2.81.
Ambea AB (CHIX:AMBEAs) Receivables Turnover Explanation
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
Ambea AB Receivables Turnover Related Terms
Ambea AB Receivables Turnover Historical Data
* Premium members only.
The historical data trend for Ambea AB's Receivables Turnover can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CHIX:AMBEAS vs HCA, THC, DVA: Receivables Turnover Comparison
For the Medical Care Facilities subindustry, Ambea AB's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ambea AB Receivables Turnover vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Ambea AB's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where Ambea AB's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ambea AB (CHIX:AMBEAS) has a Receivables Turnover of 2.81 as of Mar. 2026. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Ambea AB and its competitors. According to the industry distribution chart, Ambea AB ranks #214 out of 656 companies in the Healthcare Providers & Services industry, placing it in the top 32.6%.
Is Ambea AB's Receivables Turnover too high?
Ambea AB's current Receivables Turnover is 2.81. The Healthcare Providers & Services industry median Receivables Turnover is 7.73. Ambea AB's value of 2.81 is 63.6% below this industry median. Based on the distribution chart, Ambea AB ranks #214 out of 656 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Ambea AB has a GF Score™ of 83/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Ambea AB's Receivables Turnover compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Ambea AB ranks #214 out of 656 companies for Receivables Turnover. This puts Ambea AB in the upper half of its industry. The industry median Receivables Turnover is 7.73. Ambea AB's value of 2.81 is 63.6% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Healthcare Providers & Services company?
The median Receivables Turnover among Healthcare Providers & Services companies is 7.73, based on 656 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ambea AB's current Receivables Turnover of 2.81 is 63.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Ambea AB and its competitors. For the Healthcare Providers & Services industry, the median Receivables Turnover is 7.73 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ambea AB's current Receivables Turnover is 2.81. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ambea AB stock overvalued right now?
Based on GuruFocus' analysis, Ambea AB (CHIX:AMBEAS) is currently considered Significantly Overvalued. The stock's GF Value™ is kr110.46, compared to a current price of kr144.20 — trading 30.5% above its estimated fair value. The current Receivables Turnover is 2.81 and 63.6% below the Healthcare Providers & Services industry median of 7.73. Ambea AB's overall GF Score™ is 83/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For Ambea AB (CHIX:AMBEAS), the current Receivables Turnover is 2.81 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ambea AB (CHIX:AMBEAS) Overvalued in 2026?
Based on GuruFocus' analysis, Ambea AB stock appears to be overvalued.
The current stock price of kr144.20 is trading 30.5% above its estimated GF Value™ of kr110.46.
GuruFocus considers Ambea AB to be Significantly Overvalued.
Key valuation signals for CHIX:AMBEAS:
Receivables Turnover: 2.81
GF Value™: kr110.46 vs. price of kr144.20 (30.5% above fair value)
Industry Position: 63.6% below the Healthcare Providers & Services median (#214 of 656)
No single metric tells the full story. See the CHIX:AMBEAS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ambea AB is a Swedish care-provider group focused on elderly care, disability care, psychosocial support, housing, staffing, and training across the Nordic region. The company's segment includes: i) Nytida: Comprises social care services for children, youth and adults, in Sweden, ii) Vardaga: Comprises nursing homes and home care in Sweden, iii) Stendi: Comprises social care for children, youth and adult in Norway, iv) Validia: Comprises social care for children, v) Altiden: Comprises social care for children, youth and adults as well as elderly care in Denmark, and vi) Klara: Comprises competence and staffing solutions for elderly and social care, and student health services in Sweden. The majority of the company's revenue is derived from the Vardaga segment.
83GF Score
Get the complete analysis for CHIX:AMBEAS
Receivables Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHIX:AMBEAS has been successfully added to your 
